(Q38026922)

27 August 2017

Expert review on poliovirus immunity and transmission (English)

1 reference

27 August 2017

poliovirus

1 reference

2

Mark A Pallansch

1 reference

Radboud J Duintjer Tebbens

27 August 2017

1

object named as

Radboud J Duintjer Tebbens

1 reference

27 August 2017

9

Roland W Sutter

1 reference

27 August 2017

4

Neal A Halsey

1 reference

27 August 2017

12

Stephen L Cochi

1 reference

27 August 2017

11

Steven G F Wassilak

1 reference

27 August 2017

14

Kimberly M Thompson

1 reference

27 August 2017

Konstantin M Chumakov

3

1 reference

27 August 2017

Tapani Hovi

5

1 reference

27 August 2017

Philip D Minor

6

1 reference

27 August 2017

John F Modlin

7

1 reference

27 August 2017

Peter A Patriarca

8

1 reference

27 August 2017

Peter F Wright

10

1 reference

27 August 2017

Jong-Hoon Kim

13

1 reference

27 August 2017

15 July 2012

1 reference

27 August 2017

1 reference

27 August 2017

33

1 reference

27 August 2017

4

1 reference

27 August 2017

544-605

1 reference

Preeradication vaccine policy options for poliovirus infection and disease control.

27 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Uncertainty and sensitivity analyses of a dynamic economic evaluation model for vaccination programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Modeling population immunity to support efforts to end the transmission of live polioviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

A study of polio vaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Development of an individual-based model for polioviruses: implications of the selection of network type and outcome metrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Retrospective cost-effectiveness analyses for polio vaccination in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Eradication versus control for poliomyelitis: an economic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Inactivated poliovirus vaccine: past and present experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Vaccination against poliomyelitis with live virus vaccines. 7. Effect of previous Salk vaccination on virus excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

[THE EFFECT OF PREVACCINAL IMMUNITY ON VIRAL EXCRETION AND ANTIBODY FORMATION FOLLOWING TYPE I ORAL POLIOVIRUS VACCINATION (SABIN).]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Intrafamilial and interfamilial spread of living vaccine strains of polioviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Monovalent type 1 oral poliovirus vaccine in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Routine administration of oral polio vaccine in a subtropical area. Factors possibly influencing sero-conversion rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Effect of Prior Immunity on the Shedding of Virulent Revertant Virus in Feces after Oral Immunization with Live Attenuated Poliovirus Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Randomised, controlled trial with the trypsin-modified inactivated poliovirus vaccine: assessment of intestinal immunity with live challenge virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Fecal IgA antibody responses after oral poliovirus vaccination in infants and elder children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Preexisting poliovirus-specific IgA in the circulation correlates with protection against virus excretion in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Polio immunity to killed vaccine: an 18-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

The susceptibility of young adult Americans to vaccine-preventable infections. A national serosurvey of US Army recruits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

The response to oral poliovaccine in persons aged 16–18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Persistence of poliovirus-neutralizing antibodies 2-16 years after immunization with live attenuated vaccine. A seroepidemiologic survey in the mainland of Venice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Vaccination of families against poliomyelitis by feeding and by contact spread of living attenuated virus including studies of virus properties after human intestinal passage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

The influence of natural and artificially induced immunity on alimentary infections with polioviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

RESPONSE TO ONE DOSE OF TRIVALENT ORAL POLIOVACCINE IN CHILDREN PREVIOUSLY IMMUNISED WITH SALK VACCINE: A COMPARISON OF LIQUID VACCINE AND A CAPSULE PRESENTATION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Oral polio vaccination of children in the tropics. III. Intercurrent enterovirus infections, vaccine virus take and antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Oral polio vaccination of children in the tropics. II. Antibody response in relation to vaccine virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01864.X

Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium

21 January 2018

1 reference

12 December 2020

Early immunization of neonates with trivalent oral poliovirus vaccine

1 reference

12 December 2020

Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya

1 reference

12 December 2020

Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review

1 reference

12 December 2020

Mucosal immunity following oral poliovirus vaccine and enhanced potency inactivated poliovirus vaccine immunization

1 reference

12 December 2020

Mucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio Vaccines

1 reference

12 December 2020

Excretion of live attenuated polioviruses in the faeces of orally vaccinated children. Comparison of two immunization schedules.

1 reference

12 December 2020

Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin).

1 reference

12 December 2020

The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.

1 reference

12 December 2020

The excretion of type 1 poliovirus after challenge following primary immunization with quadruple, Salk and Sabin vaccines

1 reference

12 December 2020

Evaluation of Sabin live poliovirus vaccine in Japan. II. Clinical, virologic and immunologic effects of vaccine in children

1 reference

12 December 2020

Quantitative relationship of preexisting homotypic antibodies to excretion of poliovirus types 1, 2, and 3 following the feeding of trivalent attenuated poliovirus vaccine

1 reference

12 December 2020

Local antibody response to experimental poliovirus infection in the central nervous system of rhesus monkeys

1 reference

12 December 2020

Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter

1 reference

12 December 2020

Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1

1 reference

12 December 2020

Elimination of Poliomyelitis in Finland

1 reference

12 December 2020

Mucosal immune response to poliovirus vaccines in childhood

1 reference

12 December 2020

Viral vaccination via the mucosal routes.

1 reference

12 December 2020

Seroresponse to trivalent oral poliovirus vaccine as a function of dosage interval.

1 reference

12 December 2020

Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.

1 reference

12 December 2020

The elimination of polio in the Scandinavian countries

1 reference

12 December 2020

Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.

1 reference

12 December 2020

Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine

1 reference

12 December 2020

Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines

1 reference

12 December 2020

Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells

1 reference

12 December 2020

Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines

1 reference

12 December 2020

Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994

1 reference

12 December 2020

Direct detection of Sabin poliovirus vaccine strains in stool specimens of first-dose vaccinees by a sensitive reverse transcription-PCR method.

1 reference

12 December 2020

Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus

1 reference

12 December 2020

Eradication of poliomyelitis in Cuba: a historical perspective

1 reference

12 December 2020

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

1 reference

12 December 2020

Poliovirus-specific intestinal antibody responses coincide with decline of poliovirus excretion

1 reference

12 December 2020

Trial of a supplemental dose of four poliovirus vaccines

1 reference

12 December 2020

Seroprevalence to polio in personnel at a virology institute

1 reference

12 December 2020

Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines

1 reference

12 December 2020

Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules

1 reference

12 December 2020

Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children

1 reference

12 December 2020

Poliomyelitis infection in households; frequency of viremia and specific antibody response

1 reference

12 December 2020

Environmental studies of endemic enteric virus infections. I. Community seroimmune patterns and poliovirus infection rates

1 reference

12 December 2020

Environmental studies of endemic enteric virus infections. II. Poliovirus infections in household units

1 reference

12 December 2020

Studies on the development of natural immunity to poliomyelitis in Louisiana. I. Over-all plan, methods and observations as to patterns of seroimmunity in the study group

1 reference

12 December 2020

Studies on the development of natural immunity to poliomyelitis in Louisiana. II. Description and analysis of episodes of infection observed in study group households

1 reference

12 December 2020

Influence of prior active immunization on the presence of poliomyelitis virus in the pharynx and stools of family contacts of patients with paralytic poliomyelitis.

1 reference

12 December 2020

Attenuated type 1 poliovirus vaccine; its capacity to infect and to spread from vaccinees within an institutional population

1 reference

12 December 2020

Use of orally administered live attenuated polioviruses as a vaccine in a community setting; a controlled study

1 reference

12 December 2020

Clinical trials in infants of orally administered attenuated poliomyelitis viruses

1 reference

12 December 2020

Poliomyelitis in Des Moines, Iowa, 1959. The influence of Salk vaccination on the epidemic pattern and the spread of the virus in the community

1 reference

12 December 2020

Vaccination of adults with a British oral poliomyelitis vaccine prepared from Sabin strains

1 reference

12 December 2020

Vaccination against poliomyelitis with live virus vaccines. 6. Changes in Sabin type II oral vaccine virus after human passage

1 reference

12 December 2020

Virus excretion after mass vaccination with attenuated polioviruses in Hungary

1 reference

12 December 2020

Community-wide use of oral poliovirus vaccine. Efectiveness of the Cincinnati program

1 reference

12 December 2020

Virologic findings and antibody response of newborns fed multiple type oral poliomyelitis vaccine

1 reference

12 December 2020

Transmission of polioviruses. III. Prevalence of polioviruses in pharyngeal secretions of infected household contacts of patients with clinical disease

1 reference

12 December 2020

Transmission of polioviruses. II. Spread of attenuated poliovirus type III in a partially immunized school population.

1 reference

12 December 2020

Studies onthe development of natural immunity to poliomyelitis in Louisiana. IV. Natural infections with polioviruses following immunization with a formalin-inactivated vaccine

1 reference

12 December 2020

Effect of oral poliovirus vaccine in newborn children. II. Intestinal resistance and antibody response at 6 months in children fed type I vaccine at birth

1 reference

12 December 2020

THE RESPONSE AND THE LACK OF SPREAD IN SWEDISH SCHOOL CHILDREN GIVEN AN ATTENUATED POLIOVIRUS VACCINE PREPARED IN A HUMAN DIPLOID CELL STRAIN

1 reference

12 December 2020

POLIOVIRUS SHEDDING AND SEROCONVERSION. STUDIES OF 816 COSTA RICAN CHILDREN FED TRIVALENT VACCINE

1 reference

12 December 2020

OBSERVED AND EXPECTED POLIOMYELITIS IN THE UNITED STATES, 1958-1961

1 reference

12 December 2020

Extent of infection with poliomyelitis virus in household associates of clinical cases as determined serologically and by virus isolation using tissue culture methods

1 reference

12 December 2020

The trial use of Sabin's attenuated type 1 poliovirus vaccine in a village in southern Arizina

1 reference

12 December 2020

Immunization of preschool children with oral poliovirus vaccine (Sabin)

1 reference

12 December 2020

Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children. A family study during a type 1 poliomyelitis epidemic

1 reference

12 December 2020

Policy decision options during the first 5 years following certification of polio eradication

1 reference

12 December 2020

The role of routine polio immunization in the post-certification era.

1 reference

12 December 2020

The risks, costs, and benefits of possible future global policies for managing polioviruses

1 reference

12 December 2020

Uncertainty and sensitivity analyses of a decision analytic model for posteradication polio risk management

1 reference

12 December 2020

Role of injectable and oral polio vaccines in polio eradication

1 reference

12 December 2020

Fractional doses of inactivated poliovirus vaccine in Oman

1 reference

12 December 2020

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial

1 reference

12 December 2020

Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials

1 reference

12 December 2020

10.1111/J.1539-6924.2012.01864.X

Identifiers

DOI

1 reference

27 August 2017

0 references

1 reference